Yan Zhang, PhD, Jeanne Stuckey, PhD, Markus Ruetz, PhD, Michael Cianfrocco, PhD, and Wei Cheng, PhD, have been promoted.

The newest version of the heparin reversal drug, described in a recent issue of Advanced Healthcare Materials, adjusted the number of protons bound to it, making the molecule less positive so it would preferentially bind to the highly negative heparin, resulting in a much safer drug.

Recent research achievements from the Giessen lab.

A musician receives live donor cartilage that changes her life.

Among people with multiple sclerosis in the United States, more than half experienced at least one fall in a six-month period and approximately one-third of those falls resulted in an injury.

Dr. Meredith Skiba will join the faculty of the Departments of Biological Chemistry and Pharmacology at U-M Medical School in 2025.

At the University of Michigan Health C.S. Mott Children's Hospital, one physician found a way to help pediatric patients demonstrate different joint movements using a Barbie doll.

A growing number of people living with Alzheimer’s disease and related dementias – especially those from diverse backgrounds – receive care from a network of individuals that increasingly includes nontraditional informal caregivers.

A new collaborative study, examined the interaction between three naturally occurring gases — nitric oxide (NO), oxygen, and H2S — during generation of new blood vessels, called angiogenesis.

The Giessen lab publishes a research article in Nature Communications.

An article about a program to promote faculty diversity co-authored by Ruma Banerjee and two research articles by Banerjee lab members and their U-M collaborators have come into view this week.

Assistant Professor Yan Zhang of the Department of Biological Chemistry at U-M Medical School is the recipient of an NSF CAREER award.

PhD student Basila Moochickal Assainar is the first author of a research article in Nature Communications.

A study from the University of Michigan Medical School developed off-switches useful for improving the safety of the Type I-C/Cas3 gene editor.